TCL Archive FDA Oncology Division Director Says Goal to Make Review Process “Predictable” August 2, 1996
TCL Archive Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends November 5, 1976
TCL Archive CDC Contribution To National Dialogue Raises Questions About Ties With ACS. September 22, 2000
TCL Archive Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules July 30, 1999
